RMC-113
RMC-113 is a PIP4K2C and PIKfyve inhibitor with the Ki vaules of 46 nM and 370 nM. RMC-113 reverses SARS-CoV-2-induced impairment of autophagic flux. RMC-113 shows antiviral activity[1].
Product Specifications
CAS Number
2258606-34-5
UNSPSC
12352005
Target
Autophagy; Dengue Virus; DNA/RNA Synthesis; Filovirus; PIKfyve; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rmc-113.html
Purity
99.54
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COC1=C(OC)C=CC(C2=CC3=NSC(C#CC4=CC=CN=C4)=C3N=C2)=C1
Molecular Formula
C21H15N3O2S
Molecular Weight
373.43
References & Citations
[1]Karim M, et al. PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2. Preprint. bioRxiv. 2024;2024.04.15.589676. Published 2024 Apr 17.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV713220 1.0 µg DNA
PDLIM4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 